Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced preclinical data for STAT6 inhibitor ...
India’s shift from educational access to an "intelligent" scale requires moving beyond AI tools to AI as infrastructure. By ...
Domain mogul Daniel Negari invested hundreds of millions in offices and retail in Santa Monica and San Diego, banking on ...
Generic AI creates risk - domain-trained small language models deliver accuracy, efficiency, and security enterprises need.
As LLMs hit the limits of scale and cost, specialized SLMs are emerging as the faster, cheaper, and more private workhorse ...
Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...
Discover how OpenAI's ChatGPT 5.5 outperforms Opus 4.7 in speed and token efficiency, despite Opus 4.7 retaining an edge in ...
Stop overpaying for massive models when small, specialized ones can handle your routine tasks faster, cheaper and more ...
Sutro Biopharma underwent major restructuring, including management changes and layoffs. Read why I rate STRO stock a Strong ...
Toronto Metropolitan University’s Judith Borts examines how the rapid adoption of A.I. is reshaping cybersecurity at every ...
Hitachi leaders explain why manufacturing must reject "fail fast" culture in favour of reliable, deterministic AI to protect ...
Brightfin, the only ITFM and Technology Expense Management solution built natively on ServiceNow, today announced an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results